HEADER TRANSFERASE 11-JAN-07 2JDO TITLE STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC TITLE 2 ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-BETA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE CATALYTIC DOMAIN, RESIDUES 146-467; COMPND 5 SYNONYM: PROTEIN KINASE B-BETA, RAC-PK-BETA, PROTEIN KINASE AKT-2, COMPND 6 PROTEIN KINASE B, BETA, PKB BETA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: PIFTIDE SEQUENCE (EEQEMFEDFDYIADW) REPLACES NATURAL COMPND 10 PKB SEQUENCE AFTER RESIDUE 464; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 13 CHAIN: C; COMPND 14 FRAGMENT: RESIDUES 3-12; COMPND 15 SYNONYM: GSK3-BETA PEPTIDE, GSK-3 BETA; COMPND 16 EC: 2.7.11.26; COMPND 17 ENGINEERED: YES; COMPND 18 OTHER_DETAILS: PEPTIDE DERIVED FROM THE KINASE GSK3-BETA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS WNT SIGNALING PATHWAY, SERINE/THREONINE-PROTEIN KINASE, KINASE, KEYWDS 2 TRANSFERASE, ATP-BINDING, PHOSPHORYLATION, NUCLEOTIDE-BINDING, KEYWDS 3 ALTERNATIVE SPLICING EXPDTA X-RAY DIFFRACTION AUTHOR T.G.DAVIES,M.L.VERDONK,B.GRAHAM,S.SAALAU-BETHELL,C.C.F.HAMLETT, AUTHOR 2 T.MCHARDY,I.COLLINS,M.D.GARRETT,P.WORKMAN,S.J.WOODHEAD,H.JHOTI, AUTHOR 3 D.BARFORD REVDAT 5 06-NOV-24 2JDO 1 LINK REVDAT 4 24-FEB-09 2JDO 1 VERSN REVDAT 3 13-MAR-07 2JDO 1 JRNL REVDAT 2 27-FEB-07 2JDO 1 REMARK REVDAT 1 13-FEB-07 2JDO 0 JRNL AUTH T.G.DAVIES,M.L.VERDONK,B.GRAHAM,S.SAALAU-BETHELL, JRNL AUTH 2 C.C.F.HAMLETT,T.MCHARDY,I.COLLINS,M.D.GARRETT,P.WORKMAN, JRNL AUTH 3 S.J.WOODHEAD,H.JHOTI,D.BARFORD JRNL TITL A STRUCTURAL COMPARISON OF INHIBITOR BINDING TO PKB, PKA AND JRNL TITL 2 PKA-PKB CHIMERA JRNL REF J.MOL.BIOL. V. 367 882 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17275837 JRNL DOI 10.1016/J.JMB.2007.01.004 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 31145 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1676 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1764 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE SET COUNT : 93 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2666 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 323 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.06000 REMARK 3 B22 (A**2) : -1.22000 REMARK 3 B33 (A**2) : 1.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.130 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.122 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.454 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2760 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1937 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3719 ; 1.096 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4672 ; 0.826 ; 2.984 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 322 ; 5.557 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 137 ;34.008 ;23.285 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 495 ;12.267 ;15.222 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;15.971 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 390 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3021 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 610 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 531 ; 0.204 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2044 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1340 ; 0.182 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1370 ; 0.080 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 59 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.121 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 49 ; 0.283 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.123 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1615 ; 0.061 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 656 ; 0.025 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2604 ; 0.090 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1145 ; 0.078 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1115 ; 0.109 ; 7.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2JDO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1290031055. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97620 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31145 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 55.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.63100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.28350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.28350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.63100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 141 REMARK 465 ALA A 142 REMARK 465 MET A 143 REMARK 465 ASP A 144 REMARK 465 PRO A 145 REMARK 465 ILE A 450 REMARK 465 THR A 451 REMARK 465 PRO A 452 REMARK 465 PRO A 453 REMARK 465 ASP A 454 REMARK 465 ARG A 455 REMARK 465 TYR A 456 REMARK 465 ASP A 457 REMARK 465 SER A 458 REMARK 465 LEU A 459 REMARK 465 GLY A 460 REMARK 465 LEU A 461 REMARK 465 LEU A 462 REMARK 465 GLU A 463 REMARK 465 LEU A 464 REMARK 465 ASP A 464A REMARK 465 GLN A 464B REMARK 465 ARG A 464C REMARK 465 GLU A 465 REMARK 465 GLU A 466 REMARK 465 GLN A 467 REMARK 465 GLU A 468 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 245 -42.40 71.19 REMARK 500 ARG A 274 -4.25 72.69 REMARK 500 ASP A 293 72.21 60.46 REMARK 500 ASP A 303 -122.80 49.79 REMARK 500 ASN A 325 -154.10 77.12 REMARK 500 ASP A 399 -120.70 53.77 REMARK 500 ARG C 4 151.03 28.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2072 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH A2159 DISTANCE = 6.66 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I5S A1480 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1481 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GNG RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE 3BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE REMARK 900 RELATED ID: 1H8F RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA. REMARK 900 RELATED ID: 1I09 RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 ( GSK3B) REMARK 900 RELATED ID: 1J1B RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHAMPPNP REMARK 900 RELATED ID: 1J1C RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHADP REMARK 900 RELATED ID: 1O6K RELATED DB: PDB REMARK 900 STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 REMARK 900 PEPTIDE AND AMP-PNP REMARK 900 RELATED ID: 1O6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVATED AKT/ PROTEIN KINASE B (PKB-PIF REMARK 900 CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE REMARK 900 RELATED ID: 1O9U RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE REMARK 900 RELATED ID: 1PYX RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH AMP-PNP REMARK 900 RELATED ID: 1Q3D RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH STAUROSPORINE REMARK 900 RELATED ID: 1Q3W RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE REMARK 900 RELATED ID: 1Q41 RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'- MONOXIME REMARK 900 RELATED ID: 1Q4L RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INHIBITOR I-5 REMARK 900 RELATED ID: 1Q5K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 INCOMPLEXED WITH REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1R0E RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- REMARK 900 ARYLMALEIMIDE INHIBITOR REMARK 900 RELATED ID: 1UV5 RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'- REMARK 900 OXIME REMARK 900 RELATED ID: 1GZK RELATED DB: PDB REMARK 900 MOLECULAR MECHANISM FOR THE REGULATION OF PROTEIN KINASE B/AKT BY REMARK 900 HYDROPHOBIC MOTIF PHOSPHORYLATION REMARK 900 RELATED ID: 1GZN RELATED DB: PDB REMARK 900 STRUCTURE OF PKB KINASE DOMAIN REMARK 900 RELATED ID: 1GZO RELATED DB: PDB REMARK 900 STRUCTURE OF PROTEIN KINASE B UNPHOSPHORYLATED REMARK 900 RELATED ID: 1MRV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN REMARK 900 RELATED ID: 1MRY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN REMARK 900 RELATED ID: 1P6S RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OFHUMAN REMARK 900 PROTEIN KINASE B BETA (PKB /AKT) REMARK 900 RELATED ID: 2JDR RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654 REMARK 900 RELATED ID: 2JDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654 REMARK 900 RELATED ID: 2JDT RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC REMARK 900 ACID (2-(2-(4- CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE REMARK 900 RELATED ID: 2JDV RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654 REMARK 999 REMARK 999 SEQUENCE REMARK 999 CLONE DOES NOT CONTAIN THE FIRST 145 RESIDUES OF THE REMARK 999 P31751 SEQUENCE (PH-DOMAIN). RESIDUES GAMDP AT THE START REMARK 999 OF THE CLONED SEQUENCE ARE ARTEFACTS FROM A PURIFICATION REMARK 999 TAG, HOWEVER THESE ARE NOT VISIBLE IN THE STRUCTURE AND REMARK 999 WERE NOT BUILT. THE CLONE CONTAINS THE SEQUENCE REMARK 999 EEQEMFEDFDYIADW (PIFTIDE) INSTEAD OF THE P31751 SEQUENCE REMARK 999 FROM POSITION 465 ONWARDS. RESIDUES 450 - 468 ARE REMARK 999 DISORDERED AND HAVE NOT BEEN BUILT IN THE STRUCTURE. REMARK 999 RESIDUES 3-12 ONLY DBREF 2JDO A 141 145 PDB 2JDO 2JDO 141 145 DBREF 2JDO A 146 464C UNP P31751 AKT2_HUMAN 146 467 DBREF 2JDO A 465 479 PDB 2JDO 2JDO 465 479 DBREF 2JDO C 3 12 UNP P49841 GSK3B_HUMAN 3 12 SEQRES 1 A 342 GLY ALA MET ASP PRO LYS VAL THR MET ASN ASP PHE ASP SEQRES 2 A 342 TYR LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL SEQRES 3 A 342 ILE LEU VAL ARG GLU LYS ALA THR GLY ARG TYR TYR ALA SEQRES 4 A 342 MET LYS ILE LEU ARG LYS GLU VAL ILE ILE ALA LYS ASP SEQRES 5 A 342 GLU VAL ALA HIS THR VAL THR GLU SER ARG VAL LEU GLN SEQRES 6 A 342 ASN THR ARG HIS PRO PHE LEU THR ALA LEU LYS TYR ALA SEQRES 7 A 342 PHE GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR SEQRES 8 A 342 ALA ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU SEQRES 9 A 342 ARG VAL PHE THR GLU GLU ARG ALA ARG PHE TYR GLY ALA SEQRES 10 A 342 GLU ILE VAL SER ALA LEU GLU TYR LEU HIS SER ARG ASP SEQRES 11 A 342 VAL VAL TYR ARG ASP ILE LYS LEU GLU ASN LEU MET LEU SEQRES 12 A 342 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 A 342 CYS LYS GLU GLY ILE SER ASP GLY ALA THR MET LYS TPO SEQRES 14 A 342 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 A 342 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 A 342 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 A 342 PRO PHE TYR ASN GLN ASP HIS GLU ARG LEU PHE GLU LEU SEQRES 18 A 342 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU SER SEQRES 19 A 342 PRO GLU ALA LYS SER LEU LEU ALA GLY LEU LEU LYS LYS SEQRES 20 A 342 ASP PRO LYS GLN ARG LEU GLY GLY GLY PRO SER ASP ALA SEQRES 21 A 342 LYS GLU VAL MET GLU HIS ARG PHE PHE LEU SER ILE ASN SEQRES 22 A 342 TRP GLN ASP VAL VAL GLN LYS LYS LEU LEU PRO PRO PHE SEQRES 23 A 342 LYS PRO GLN VAL THR SER GLU VAL ASP THR ARG TYR PHE SEQRES 24 A 342 ASP ASP GLU PHE THR ALA GLN SER ILE THR ILE THR PRO SEQRES 25 A 342 PRO ASP ARG TYR ASP SER LEU GLY LEU LEU GLU LEU ASP SEQRES 26 A 342 GLN ARG GLU GLU GLN GLU MET PHE GLU ASP PHE ASP TYR SEQRES 27 A 342 ILE ALA ASP TRP SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 2JDO TPO A 309 THR PHOSPHOTHREONINE HET TPO A 309 11 HET I5S A1480 28 HET EDO A1481 4 HETNAM TPO PHOSPHOTHREONINE HETNAM I5S ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) HETNAM 2 I5S ETHYLAMINO)ETHYL)AMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 I5S C20 H22 CL N3 O3 S FORMUL 4 EDO C2 H6 O2 FORMUL 5 HOH *323(H2 O) HELIX 1 1 THR A 148 ASN A 150 5 3 HELIX 2 2 LYS A 185 LYS A 191 1 7 HELIX 3 3 GLU A 193 ASN A 206 1 14 HELIX 4 4 GLU A 236 ARG A 245 1 10 HELIX 5 5 THR A 248 ARG A 269 1 22 HELIX 6 6 LYS A 277 GLU A 279 5 3 HELIX 7 7 THR A 313 LEU A 317 5 5 HELIX 8 8 ALA A 318 GLU A 323 5 6 HELIX 9 9 ALA A 330 GLY A 346 1 17 HELIX 10 10 ASP A 354 GLU A 365 1 12 HELIX 11 11 SER A 374 LEU A 385 1 12 HELIX 12 12 ASP A 399 GLU A 405 1 7 HELIX 13 13 HIS A 406 LEU A 410 5 5 HELIX 14 14 ASN A 413 LYS A 420 1 8 HELIX 15 15 ASP A 440 ALA A 445 1 6 SHEET 1 AA 6 PHE A 152 GLY A 161 0 SHEET 2 AA 6 GLY A 164 GLU A 171 -1 O GLY A 164 N GLY A 161 SHEET 3 AA 6 TYR A 177 ARG A 184 -1 O TYR A 178 N VAL A 169 SHEET 4 AA 6 ARG A 224 GLU A 230 -1 O LEU A 225 N LEU A 183 SHEET 5 AA 6 LEU A 215 GLN A 220 -1 N LYS A 216 O VAL A 228 SHEET 6 AA 6 TYR A 475 ILE A 476 -1 O TYR A 475 N ALA A 218 SHEET 1 AB 2 LEU A 281 LEU A 283 0 SHEET 2 AB 2 ILE A 289 ILE A 291 -1 O LYS A 290 N MET A 282 SHEET 1 AC 2 PHE A 310 GLY A 312 0 SHEET 2 AC 2 PHE C 10 GLU C 12 -1 O PHE C 10 N GLY A 312 LINK C LYS A 308 N TPO A 309 1555 1555 1.33 LINK C TPO A 309 N PHE A 310 1555 1555 1.33 SITE 1 AC1 20 LYS A 160 GLY A 161 GLY A 164 LYS A 165 SITE 2 AC1 20 VAL A 166 ALA A 179 LYS A 181 MET A 229 SITE 3 AC1 20 GLU A 230 TYR A 231 ALA A 232 GLU A 236 SITE 4 AC1 20 GLU A 279 ASN A 280 MET A 282 ASP A 293 SITE 5 AC1 20 EDO A1481 HOH A2309 HOH A2310 ARG C 6 SITE 1 AC2 6 GLU A 200 MET A 229 ASP A 293 PHE A 294 SITE 2 AC2 6 I5S A1480 HOH A2310 CRYST1 45.262 60.700 132.567 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022094 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016474 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007543 0.00000